Sort by
Refine Your Search
-
University of Basel, Condensed Matter Theory and Quantum Computing Position ID: University of Basel -Condensed Matter Theory and Quantum Computing -PHD [#21542] Position Title: Position Type
-
through lattice chemistry. The goal of the doctoral project is to explore the potential of the chemistry of the lattice (charged off-stoichiometric layers, chemical variation in layered compounds, etc
-
We invite applications for a PhD position in computer-aided drug design at the Computational Pharmacy Group, Department of Pharmaceutical Sciences, University of Basel. This position is part of
-
. Together with our team of experienced scientists, postdocs and PhD students, you will develop materials that contribute to the development of the next generation of bio-based hybrid materials. The goal
-
. Together with our team of experienced scientists, postdocs and PhD students, you will develop materials that contribute to the development of the next generation of advanced hydrogels for wound care
-
with our team of experienced scientists, postdocs and PhD students, you will develop materials that contribute to the development of the next generation of sustainable biocomposite materials. This project is
-
100%, starting January 2026 (negotiable) Proteins must fold correctly to function, and this process is tightly regulated by a network of chaperone proteins. At the heart of this network is Hsp90, a molecular chaperone essential for the folding and maturation of at least 20% of all cellular...
-
as possible. Applications are evaluated on a rolling basis until the position is filled. Profile Master's degree in Materials Science, Chemistry, Mechanical Engineering, Electrical Engineering, or
-
100%, Zurich, fixed-term The research group for Chemical Biology and Molecular Imaging (Frei Research Group ) at ETH Zurich is looking for a doctoral researcher to develop chemistry inspired tools
-
of this project, you will work with a team of scientists with backgrounds in chemistry, cell biology and microbiology as well as with clinical partners on the development of engineered corneal transplant to treat